Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain
暂无分享,去创建一个
[1] Y. Sasaguri,et al. Depletion of apoptosis signal-regulating kinase 1 prevents bile duct ligation-induced necroinflammation and subsequent peribiliary fibrosis. , 2014, The American journal of pathology.
[2] S. Hunt,et al. Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn , 2014, Molecular pain.
[3] G. Giesler,et al. Itch and Analgesia Resulting from Intrathecal Application of Morphine: Contrasting Effects on Different Populations of Trigeminothalamic Tract Neurons , 2013, The Journal of Neuroscience.
[4] F. Cattaruzza,et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. , 2013, The Journal of clinical investigation.
[5] K. Reddy,et al. Pruritus in chronic cholestatic liver disease. , 2012, Clinics in liver disease.
[6] E. Ozdemir,et al. The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats , 2012, The Journal of Physiological Sciences.
[7] Dori Seccareccia,et al. Pruritus in palliative care: Getting up to scratch. , 2011, Canadian family physician Medecin de famille canadien.
[8] Viviana Trezza,et al. Nucleus Accumbens μ-Opioid Receptors Mediate Social Reward , 2011, The Journal of Neuroscience.
[9] F. Noble,et al. Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization , 2011, Psychopharmacology.
[10] G. Koob,et al. Individual differences in prefrontal cortex function and the transition from drug use to drug dependence , 2010, Neuroscience & Biobehavioral Reviews.
[11] Satoshi Ikemoto,et al. Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory , 2010, Neuroscience & Biobehavioral Reviews.
[12] D. Davies,et al. Role of aquaporin-4 in the development of brain oedema in liver failure. , 2010, Journal of hepatology.
[13] Z. Ackerman,et al. Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation , 2010, British journal of pharmacology.
[14] E. Berry,et al. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. , 2009, Journal of hepatology.
[15] F. Porreca,et al. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors , 2009, Brain Research.
[16] Vasco Galhardo,et al. Forebrain pain mechanisms , 2009, Brain Research Reviews.
[17] Linda R Watkins,et al. The Medial Prefrontal Cortex Regulates the Differential Expression of Morphine-Conditioned Place Preference Following a Single Exposure to Controllable or Uncontrollable Stress , 2009, Neuropsychopharmacology.
[18] A. Carmichael,et al. Opioid antagonist for pruritus of cholestasis unmasking bony metastases. , 2009, Acta dermato-venereologica.
[19] V. Felipo,et al. Brain cholinergic impairment in liver failure , 2008, Brain : a journal of neurology.
[20] W. Jochum,et al. Characterization of time‐related changes after experimental bile duct ligation , 2008, The British journal of surgery.
[21] M. Marone,et al. Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample , 2001, Biological Procedures Online.
[22] Ho Tak Lau,et al. Micro-dissection of rat brain for RNA or protein extraction from specific brain region. , 2007, Journal of visualized experiments : JoVE.
[23] K. Okuse. Pain signalling pathways: from cytokines to ion channels. , 2007, The international journal of biochemistry & cell biology.
[24] Mellar P. Davis. Cholestasis and Endogenous Opioids , 2007, Clinical pharmacokinetics.
[25] M. Swain,et al. Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated. , 2006, Journal of hepatology.
[26] N. Bergasa,et al. The delta opioid receptor 1 is expressed by proliferating bile ductules in rats with cholestasis: implications for the study of liver regeneration and malignant transformation of biliary epithelium. , 2005, Medical hypotheses.
[27] R. Butterworth,et al. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. , 2004, Journal of hepatology.
[28] Sergio Tufik,et al. Afferent pain pathways: a neuroanatomical review , 2004, Brain Research.
[29] M. Steinhoff,et al. Neurophysiology of pruritus: interaction of itch and pain. , 2003, Archives of dermatology.
[30] E. Rodríguez-Garay. Cholestasis: human disease and experimental animal models. , 2003, Annals of hepatology.
[31] M. Ohsawa,et al. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. , 2000, The Journal of pharmacology and experimental therapeutics.
[32] M. Millan,et al. The induction of pain: an integrative review , 1999, Progress in Neurobiology.
[33] G. Keil,et al. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. , 1995, The Journal of pharmacology and experimental therapeutics.
[34] W. Young,et al. Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. , 1995, The American journal of physiology.
[35] D. Alling,et al. Cholestasis in the male rat is associated with naloxone-reversible antinociception. , 1994, Journal of hepatology.
[36] N. Bergasa,et al. The pruritus of cholestasis , 1999, Hepatology.
[37] N. Bergasa,et al. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. , 1992, Gastroenterology.
[38] N. Bergasa,et al. Central mu-opioid receptors are down-regulated in a rat model of cholestasis. , 1992, Journal of hepatology.
[39] M. Ossipov,et al. Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. , 1990, Anesthesiology.
[40] A. Gulati,et al. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. , 1990, European journal of pharmacology.